Overview
Catherine Chu is the director of the Division of Pediatric Neurology and the John M. Freeman Pediatric Epilepsy Center in the Johns Hopkins Department of Neurology, as well as the vice president of child neurology at the Kennedy Krieger Institute. As a child neurologist, epileptologist and clinical neurophysiologist, Dr. Chu cares for children diagnosed with epilepsy and disorders of the nervous system (neurophysiology). She specializes in electroencephalogram (also known as EEG) analysis, seizure localization, surgical planning and neuromodulation for adult and pediatric patients with difficult to control epilepsy. She is nationally and internationally recognized for her work identifying causes of and treatment options for cognitive dysfunction and seizures in epilepsy and neurodevelopmental disorders. Dr. Chu’s team specializes in identifying and developing tools to detect and understand brain rhythms that support complex cognitive functions throughout development, including how these rhythms are disrupted by seizures and neurodevelopmental disorders. Dr. Chu earned her medical degree and a master’s degree in social anthropology from Harvard University. She completed an internship in pediatrics at Massachusetts General Hospital, and then a residency in neurology and child neurology at Massachusetts General and Brigham and Women’s Hospital. After completing two fellowships at Massachusetts General, one in epilepsy and another in clinical neurophysiology, Dr. Chu earned a master’s degree in medical science, focused on clinical investigation, from Harvard Medical School.
Dr. Chu is rated as an Experienced provider by MediFind in the treatment of Encephalitis. Her top areas of expertise are Benign Rolandic Epilepsy, Epilepsy in Children, Seizures, and Epilepsy.
Her clinical research consists of co-authoring 133 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Encephalitis.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
601 North Caroline Street, Floor 5, Floor 5, Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Anusha Yeshokumar is a Pediatric Neurologist and a Neurologist in Baltimore, Maryland. Dr. Yeshokumar is rated as a Distinguished provider by MediFind in the treatment of Encephalitis. Her top areas of expertise are Anti-NMDA Receptor Encephalitis, Encephalitis, Stiff Person Syndrome, and Seizures.
Ilana Kahn is a Pediatric Neurologist and a Neurologist in Washington, Washington, D.c.. Dr. Kahn is rated as an Advanced provider by MediFind in the treatment of Encephalitis. Her top areas of expertise are Anti-NMDA Receptor Encephalitis, Encephalitis, Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, and Landau-Kleffner Syndrome.
Johns Hopkins Outpatient Center
Brenda Banwell is the director of the Department of Pediatrics, as well as pediatrician-in-chief and co-director of Johns Hopkins Children’s Center, where she helps manage the hospital’s many clinical and research centers. Dr. Banwell is a renowned expert in the research and treatment of pediatric multiple sclerosis (MS) and other neuroimmune disorders. She specializes in and studies the use of neuroimaging to assess the clinical and cognitive impact of the conditions, as well as the function of the immune system in children with these disorders. She also created a standardized clinical care algorithm and clinical database in order to evaluate the clinical impact of MS. Dr. Banwell has published more than 250 manuscripts in high-impact journals, along with over 25 book chapters. In addition, she has over 200 national and international invited lectureships and visiting professorships. An advocate for pediatric multiple sclerosis needs and research, Dr. Banwell serves as chair of the International Medical and Scientific Board of the Multiple Sclerosis International Federation, and the Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease (MOGAD) International Research Consortium. She is also chair of the pediatric committee of the National Institutes of Health NeuroNEXT program, which conducts studies on treatments for neurological diseases through academic, private, and industry collaborations. Dr. Banwell currently serves as past-chair of the International Pediatric Multiple Sclerosis Study Group, Dr. Banwell earned her medical degree from the University of Western Ontario. She later completed a residency in pediatrics at the University of Western Ontario-Children's Hospital of Western Ontario and a second residency in pediatric neurology at University of Toronto – The Hospital for Sick Children. Her residencies were followed by a fellowship in neuromuscular research at Mayo Clinic. Dr. Banwell is rated as an Elite provider by MediFind in the treatment of Encephalitis. Her top areas of expertise are Multiple Sclerosis (MS), CACH Syndrome, Optic Neuritis, and Transverse Myelitis.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Benign Rolandic Epilepsy
- EpilepsyDr. Chu isElite. Learn about Epilepsy.
- Epilepsy in ChildrenDr. Chu isElite. Learn about Epilepsy in Children.
- SeizuresDr. Chu isElite. Learn about Seizures.
- Distinguished
- Absence SeizureDr. Chu isDistinguished. Learn about Absence Seizure.
- Angelman SyndromeDr. Chu isDistinguished. Learn about Angelman Syndrome.
- Generalized Tonic-Clonic SeizureDr. Chu isDistinguished. Learn about Generalized Tonic-Clonic Seizure.
- Spasmus NutansDr. Chu isDistinguished. Learn about Spasmus Nutans.
- West SyndromeDr. Chu isDistinguished. Learn about West Syndrome.
- Advanced
- Status EpilepticusDr. Chu isAdvanced. Learn about Status Epilepticus.
- Experienced
- Autism Spectrum DisorderDr. Chu isExperienced. Learn about Autism Spectrum Disorder.
- Cerebral PalsyDr. Chu isExperienced. Learn about Cerebral Palsy.
- Cortical DysplasiaDr. Chu isExperienced. Learn about Cortical Dysplasia.
- EncephalitisDr. Chu isExperienced. Learn about Encephalitis.
- Herpes Simplex EncephalitisDr. Chu isExperienced. Learn about Herpes Simplex Encephalitis.
- MELAS SyndromeDr. Chu isExperienced. Learn about MELAS Syndrome.